|
|
SPOT ON
|
|
Orphan drug pirfenidone (ESBRIET): benefit legally enacted
Summary of product characteristics - updated at a snail´s pace
|
|
|
NEW ON THE MARKET
|
|
Botulinum toxin type A (BOTOX) against chronic migraine |
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Discount contracts: boon or bane?
Tamoxifen and CYP 2D6 testing: what´s new?
|
|
|
IN BRIEF
|
|
Recourse due to fictitiously approved drugs
Pancreatitis - sitagliptin (JANUVIA, XELEVIA) safety study is overdue
Confirmed - ADHD more often diagnosed in the youngest children of a class
Association Voluntary Self-Regulation for the Pharmaceutical Industry (Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.) on "ordering" of samples via the courier
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Fatal rhabdomyolysis following isotretionin |
|
|
SIDE EFFECTS
|
|
Severe allergy to mould fungus homeopathics
Severe hypersensitivity reaction against gout medication febuxostat (ADENURIC)
New contraindication for strontium ranelate (PROTELOS)
|
|
|
e a-t IN INTERNET
|
|
Fictitiously approved drugs: information supplementing the in brief story
|
|